NR-305:| NR 305 HEALTH ASSESSMENT FINAL EXAM QUESTIONS WITH 100% CORRECT ANSWERS| GRADED A+
NR-305:| NR 305 HEALTH ASSESSMENT FINAL EXAM QUESTIONS WITH 100% CORRECT ANSWERS| GRADED A+During therapy with hemtopoietic drugs, the nurse will monitor the patient for which adverse effects? SATA a. diarrhea b. edema c. nausea and vomiting d. hypotension e. headache f. black tarry stools a,b,c,e A patient is to receive filgrastim (Neupogen) 5 mcg/kg/day. The patient weighs 198 lbs. Calculate how many micrograms of medication this patient will receive each day. a. 450 mcg b. 4.5 mcg c. 45 mcg d. 4500 mcg a What is the general action of immunosuppressants? a. they inhibit T-lymphocytes b. they increase natural killer cellular activity c. they increase antibody response d. they re hepatic metabolism of steroids a The nurse should teach the client about which expected adverse effect of filgastrim (Neupogen)? a. insomnia b. constipation c. bone pain d. hypotension c
Written for
- Institution
- NR-305:| NR 305 HEALTH ASSESSMENT
- Course
- NR-305:| NR 305 HEALTH ASSESSMENT
Document information
- Uploaded on
- April 30, 2024
- Number of pages
- 69
- Written in
- 2023/2024
- Type
- Exam (elaborations)
- Contains
- Questions & answers
Subjects
-
nr 305 health assessment
-
nr 305
-
nr 305 nr 305 health assessment final exam quest
-
nr 305 nr 305 health assessment final exam
-
during therapy with hemtopoietic drugs the nurse
Also available in package deal